Current role
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
Jason B. Shandell
General Counsel
Amphastar Pharmaceuticals, Inc. (AMPH)Equibles does not estimate personal net worth.
Get an email with a short summary when Amphastar Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMPH alertsAbout Jason B. Shandell
Jason B. Shandell is recorded as General Counsel at Amphastar Pharmaceuticals, Inc. (AMPH). The proxy statement of Amphastar Pharmaceuticals, Inc. reports total compensation of $2,924,141 for Jason B. Shandell in fiscal 2019, including a base salary of $869,996. Disclosed compensation is on record for 3 fiscal years. Amphastar Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amphastar Pharmaceuticals, Inc. includes Jack Yongfeng Zhang (CEO and Board Member), William J. Peters (CFO and Board Member), William Peters (CFO) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Amphastar Pharmaceuticals, Inc.
- Jack Yongfeng Zhang CEO, Board Member
- William J. Peters CFO, Board Member
- William Peters CFO
- Mary Ziping Luo COO, Board Member
- Anthony Pierce Board Member
- David Gaugh Board Member
- Gayle Deflin Board Member
- Howard Lee Board Member
- Jacob Liawatidewi Board Member
- Michael A. Zasloff Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Amphastar Pharmaceuticals, Inc. (AMPH) | Former President, General Counsel and Director | $869,996 | $2,924,141 |
| 2018 | Amphastar Pharmaceuticals, Inc. (AMPH) | Former President, General Counsel and Director | $593,616 | $2,584,387 |
| 2017 | Amphastar Pharmaceuticals, Inc. (AMPH) | Former President, General Counsel and Director | $574,001 | $2,614,927 |
Recent activity
No call appearances or filed executive changes recorded yet.